Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 27, 2018 Filed Jul 27, 2018 17:45 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
SaleCommon Stock | 32,846 | $122.92 | $4,037,351.49 |
DisclosureSEC source: 0001209191-18-044262 · doc4.xml · nonDerivative · entry 5 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,845.6171 F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.28 to $123.27, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 27, 2018 Filed Jul 27, 2018 17:44 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
SaleCommon Stock | 1,530 | $124.47 | $190,439.10 |
DisclosureSEC source: 0001209191-18-044260 · doc4.xml · nonDerivative · entry 3 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,057 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 18:48 UTC |
Foster Jon MGroup President
|
Exercise / conversionStock Appreciation Right · Derivative | 100,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-044603 · doc4.xml · derivative · entry 4 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 18:48 UTC |
Foster Jon MGroup President
|
Tax withholdingCommon Stock | 50,562 | $124.15 | $6,277,272.30 |
DisclosureSEC source: 0001209191-18-044603 · doc4.xml · nonDerivative · entry 2 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,492 Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 18:48 UTC |
Foster Jon MGroup President
|
Exercise / conversionCommon Stock | 100,000 | $22.95 | $2,295,000.00 |
DisclosureSEC source: 0001209191-18-044603 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 18:49 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 35,625 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-044604 · doc4.xml · derivative · entry 5 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,625 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 18:49 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 37,500 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-044604 · doc4.xml · derivative · entry 4 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 18:49 UTC |
Paslick P. MartinSVP and CIO
|
Tax withholdingCommon Stock | 42,059 | $124.15 | $5,221,624.85 |
DisclosureSEC source: 0001209191-18-044604 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,263 Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 18:49 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionCommon Stock | 73,125 | $37.18 | $2,718,787.50 |
DisclosureSEC source: 0001209191-18-044604 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 18:46 UTC |
CAMPBELL VICTOR LSVP-Invest Rel & Govt Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 26,125 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-044601 · doc4.xml · derivative · entry 9 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Invest Rel & Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,125 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 18:46 UTC |
CAMPBELL VICTOR LSVP-Invest Rel & Govt Affairs
|
Exercise / conversionStock Appreciation Right · Derivative | 27,500 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-044601 · doc4.xml · derivative · entry 8 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Invest Rel & Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,500 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 18:46 UTC |
CAMPBELL VICTOR LSVP-Invest Rel & Govt Affairs
|
Tax withholdingCommon Stock | 30,843 | $124.15 | $3,829,158.45 |
DisclosureSEC source: 0001209191-18-044601 · doc4.xml · nonDerivative · entry 2 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Invest Rel & Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,650 Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 18:46 UTC |
CAMPBELL VICTOR LSVP-Invest Rel & Govt Affairs
|
Exercise / conversionCommon Stock | 53,625 | $37.18 | $1,993,777.50 |
DisclosureSEC source: 0001209191-18-044601 · doc4.xml · nonDerivative · entry 1 CAMPBELL VICTOR L · CIK 0001216831 · SVP-Invest Rel & Govt Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:36 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionStock Appreciation Right · Derivative | 8,075 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-044396 · doc4.xml · derivative · entry 5 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,075 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:36 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionStock Appreciation Right · Derivative | 8,500 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-044396 · doc4.xml · derivative · entry 4 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,500 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:36 UTC |
Wyatt Christopher F.SVP & Controller
|
Tax withholdingCommon Stock | 9,356 | $124.30 | $1,162,950.80 |
DisclosureSEC source: 0001209191-18-044396 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,628 Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:36 UTC |
Wyatt Christopher F.SVP & Controller
|
Exercise / conversionCommon Stock | 16,575 | $37.18 | $616,258.50 |
DisclosureSEC source: 0001209191-18-044396 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:34 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionStock Appreciation Right · Derivative | 12,500 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-044391 · doc4.xml · derivative · entry 5 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:34 UTC |
Cuffe Michael S.President-Physician Services
|
GiftCommon Stock | 589 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-044391 · doc4.xml · nonDerivative · entry 3 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,160.2979 F1 · balance_after: Includes 1540.2979 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:34 UTC |
Cuffe Michael S.President-Physician Services
|
Tax withholdingCommon Stock | 7,187 | $124.30 | $893,344.10 |
DisclosureSEC source: 0001209191-18-044391 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,749.2979 F1 · balance_after: Includes 1540.2979 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:34 UTC |
Cuffe Michael S.President-Physician Services
|
Exercise / conversionCommon Stock | 12,500 | $37.18 | $464,750.00 |
DisclosureSEC source: 0001209191-18-044391 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,936.2979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1540.2979 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:32 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
Exercise / conversionStock Appreciation Right · Derivative | 1,875 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-044387 · doc4.xml · derivative · entry 9 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,875 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:32 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
Exercise / conversionStock Appreciation Right · Derivative | 1,875 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-044387 · doc4.xml · derivative · entry 8 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,875 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:32 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,125 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-18-044387 · doc4.xml · derivative · entry 7 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,125 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:32 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
Tax withholdingCommon Stock | 1,898 | $124.30 | $235,921.40 |
DisclosureSEC source: 0001209191-18-044387 · doc4.xml · nonDerivative · entry 4 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,186.2342 F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 860.2342 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:32 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
Exercise / conversionCommon Stock | 3,750 | $22.95 | $86,062.50 |
DisclosureSEC source: 0001209191-18-044387 · doc4.xml · nonDerivative · entry 3 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,084.2342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 860.2342 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:32 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
SaleCommon Stock | 3,125 | $119.81 | $374,406.25 |
DisclosureSEC source: 0001209191-18-044387 · doc4.xml · nonDerivative · entry 2 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,334.2342 F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 860.2342 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 26, 2018 Filed Jul 30, 2018 16:32 UTC |
Morrow J WilliamSVP - Finance and Treasurer
|
Exercise / conversionCommon Stock | 3,125 | $17.33 | $54,156.25 |
DisclosureSEC source: 0001209191-18-044387 · doc4.xml · nonDerivative · entry 1 Morrow J William · CIK 0001696543 · SVP - Finance and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,459.2342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 860.2342 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 26, 2018 Filed Feb 1, 2019 18:02 UTC |
Morgan Sandra L.SVP-Provider Relations
|
SaleCommon Stock | 1,913 | $122.29 | $233,941.54 |
DisclosureSEC source: 0001209191-19-006579 · doc4.xml · nonDerivative · entry 1 Morgan Sandra L. · CIK 0001632836 · SVP-Provider Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,592.8654 Read SEC document |
| July 25, 2018 Filed Jul 25, 2018 16:41 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
SaleCommon Stock | 237 | $112.53 | $26,669.61 |
DisclosureSEC source: 0001209191-18-043898 · doc4.xml · nonDerivative · entry 3 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,432 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 25, 2018 Filed Jul 25, 2018 16:39 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
SaleCommon Stock | 1,689 | $112.53 | $190,063.17 |
DisclosureSEC source: 0001209191-18-043895 · doc4.xml · nonDerivative · entry 3 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,057 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:45 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionStock Appreciation Right · Derivative | 75,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-044262 · doc4.xml · derivative · entry 12 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:45 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionStock Appreciation Right · Derivative | 75,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-18-044262 · doc4.xml · derivative · entry 11 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:45 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0001209191-18-044262 · doc4.xml · derivative · entry 10 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:45 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Tax withholdingCommon Stock | 76,702 | $118.13 | $9,060,807.26 |
DisclosureSEC source: 0001209191-18-044262 · doc4.xml · nonDerivative · entry 4 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,691.6171 F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:45 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionCommon Stock | 150,000 | $22.95 | $3,442,500.00 |
DisclosureSEC source: 0001209191-18-044262 · doc4.xml · nonDerivative · entry 3 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,393.6171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:45 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
SaleCommon Stock | 10,000 | $112.53 | $1,125,300.00 |
DisclosureSEC source: 0001209191-18-044262 · doc4.xml · nonDerivative · entry 2 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,393.6171 F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:45 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionCommon Stock | 10,000 | $22.10 | $221,000.00 |
DisclosureSEC source: 0001209191-18-044262 · doc4.xml · nonDerivative · entry 1 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,393.6171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:44 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 4,250 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-18-044260 · doc4.xml · derivative · entry 4 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,250 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:44 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Tax withholdingCommon Stock | 2,720 | $118.13 | $321,313.60 |
DisclosureSEC source: 0001209191-18-044260 · doc4.xml · nonDerivative · entry 2 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,587 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 17:44 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 4,250 | $47.97 | $203,872.50 |
DisclosureSEC source: 0001209191-18-044260 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 16:41 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionStock Appreciation Right · Derivative | 1,605 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-18-043898 · doc4.xml · derivative · entry 4 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,815 Underlying: Common Stock · 1,605 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 16:41 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Tax withholdingCommon Stock | 1,368 | $108.36 | $148,236.48 |
DisclosureSEC source: 0001209191-18-043898 · doc4.xml · nonDerivative · entry 2 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,669 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 16:41 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Exercise / conversionCommon Stock | 1,605 | $81.96 | $131,545.80 |
DisclosureSEC source: 0001209191-18-043898 · doc4.xml · nonDerivative · entry 1 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 16:39 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionStock Appreciation Right · Derivative | 5,000 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-18-043895 · doc4.xml · derivative · entry 4 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 16:39 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Tax withholdingCommon Stock | 3,311 | $108.36 | $358,779.96 |
DisclosureSEC source: 0001209191-18-043895 · doc4.xml · nonDerivative · entry 2 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,746 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| July 23, 2018 Filed Jul 25, 2018 16:39 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Exercise / conversionCommon Stock | 5,000 | $47.97 | $239,850.00 |
DisclosureSEC source: 0001209191-18-043895 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 16:31 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $21.35 | $0.00 |
DisclosureSEC source: 0001209191-18-039404 · doc4.xml · derivative · entry 5 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 16:31 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
SaleCommon Stock | 12,500 | $108.00 | $1,350,000.00 |
DisclosureSEC source: 0001209191-18-039404 · doc4.xml · nonDerivative · entry 2 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,393.6171 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 16:31 UTC |
Perlin Jonathan BPres-Clinical Services & CMO
|
Exercise / conversionCommon Stock | 12,500 | $21.35 | $266,875.00 |
DisclosureSEC source: 0001209191-18-039404 · doc4.xml · nonDerivative · entry 1 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,893.6171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.